The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Guidelines of care for the management of psoriasis and psoriatic arthritis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
FINLAY, A. Y., & KHAN, G. K. (1994) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1994.tb01167.x · Cited by 5,586
Severe Psoriasis – Oral Therapy with a New Retinoid
Fredriksson, T., & Pettersson, U. (2009) · Dermatologica · doi:10.1159/000250839 · Cited by 2,718
Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I., Matteson, E. L., & Montori, V. (2006) · JAMA · doi:10.1001/jama.295.19.2275 · Cited by 2,468
Risk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899 · cited 2×
“Several factors are believed to contribute to the increased risk for cardiovascular disease in these patients.(11) Patients with psoriasis are more frequently overweight, have an increased incidence of diabetes, have an increased incidence of hypertension, and have an atherogenic lipoprotein profile at the onset of ps…”
BackgroundPsoriasis causes as much disability as other major medical diseases
Rapp, S. R., Feldman, S. R., Exum, M. L., Fleischer, A. B., & Reboussin, D. M. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70112-x · Cited by 1,491
Self-citationMann, D. L., McMurray, J. J. V., Packer, M., Swedberg, K., Borer, J. S., Colucci, W. S., Djian, J., Drexler, H., Feldman, A., Kober, L., et al. (2004) · Circulation · doi:10.1161/01.cir.0000124490.27666.b2 · Cited by 1,240
Etanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175
Self-citationTyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069 · cited 3×
“Therefore, treatment of psoriasis with etanercept lessened symptoms of depression in patients without overt clinical depression.(32) Increased rates of depression in patients with psoriasis may be another factor leading to increased risk of cardiovascular disease.”
BackgroundResultSelf-citationReich, K., Nestle, F. O., Papp, K., Ortonne, J.-P., Evans, R., Guzzo, C., Li, S., Dooley, L. T., & Griffiths, C. E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67566-6 · Cited by 1,045
Prevalence of cardiovascular risk factors in patients with psoriasis
Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., Troxel, A. B., & Gelfand, J. M. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.040 · Cited by 1,010
Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor Antagonists
Wallis, R. S., Broder, M. S., Wong, J. Y., Hanson, M. E., & Beenhouwer, D. O. (2004) · Clinical Infectious Diseases · doi:10.1086/383317 · Cited by 977
Krueger, G. G., Koo, J. Y. M., Lebwohl, M., Menter, A., Stern, R. S., & Rolstad, T. (2001) · PubMed · Cited by 969
Self-citationEfficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
Chaudhari, U., Romano, P., Mulcahy, L., Dooley, L., Baker, D., & Gottlieb, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04954-0 · Cited by 890
Self-citationAdalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Menter, A., Tyring, S. K., Gordon, K., Kimball, A. B., Leonardi, C. L., Langley, R. G., Strober, B. E., Kaul, M., Gu, Y., Okun, M., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.09.010 · Cited by 889
Self-citationGupta, & Gupta (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02511.x · Cited by 864
A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis
Krueger, G. G., Langley, R. G., Leonardi, C., Yeilding, N., Guzzo, C., Wang, Y., Dooley, L. T., & Lebwohl, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062382 · Cited by 807
Self-citationStern, R. S., Nijsten, T., Feldman, S. R., Margolis, D. J., & Rolstad, T. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2003.09102.x · Cited by 732
Self-citationMean body weight, height, and body mass index, United States 1960-2002.
Ogden, C. L., Fryar, C. D., Carroll, M. D., & Flegal, K. M. (2004) · PubMed · Cited by 717
Papp, K. A., Tyring, S., Lahfa, M., Prinz, J., Griffiths, C. E. M., Nakanishi, A. M., Zitnik, R., van de Kerkhof, P. C. M., & the Etanercept Psoriasis Study Group (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06688.x · Cited by 693
Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case?control study
Gisondi, P., Tessari, G., Conti, A., Piaserico, S., Schianchi, S., Peserico, A., Giannetti, A., & Girolomoni, G. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07986.x · Cited by 675
Stern, R. S., Nichols, K. T., & Väkevä, L. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361501 · Cited by 656
Brown, S. L., Greene, M. H., Gershon, S. K., Edwards, E. T., & Braun, M. M. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10679 · Cited by 655
Naldi, L., Chatenoud, L., Linder, D., Belloni Fortina, A., Peserico, A., Virgili, A. R., Bruni, P. L., Ingordo, V., Scocco, G. L., Solaroli, C., et al. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23681.x · Cited by 642
Antoni, C. E., Kavanaugh, A., Kirkham, B., Tutuncu, Z., Burmester, G. R., Schneider, U., Furst, D. E., Molitor, J., Keystone, E., Gladman, D., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20967 · Cited by 640
Langley, R. G., & Ellis, C. N. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.04.012 · Cited by 614
Sequence and Haplotype Analysis Supports HLA-C as the Psoriasis Susceptibility 1 Gene
Nair, R. P., Stuart, P. E., Nistor, I., Hiremagalore, R., Chia, N. V. C., Jenisch, S., Weichenthal, M., Abecasis, G. R., Lim, H. W., Christophers, E., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503821 · Cited by 606
Prevalence and Treatment of Psoriasis in the United Kingdom: A Population-Based Study
Gelfand, J. M., Weinstein, R., Porter, S. B., Neimann, A. L., Berlin, J. A., & Margolis, D. J. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.12.1537 · Cited by 600
Treatment of Chronic Plaque Psoriasis by Selective Targeting of Memory Effector T Lymphocytes
Ellis, C. N., & Krueger, G. G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450403 · Cited by 582
Gottlieb, A. B., Evans, R., Li, S., Dooley, L. T., Guzzo, C. A., Baker, D., Bala, M., Marano, C. W., & Menter, A. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.02.021 · Cited by 581
Self-citationA Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis
Lebwohl, M., Tyring, S. K., Hamilton, T. K., Toth, D., Glazer, S., Tawfik, N. H., Walicke, P., Dummer, W., Wang, X., Garovoy, M. R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030002 · Cited by 570
Self-citationMohan, V. P., Scanga, C. A., Yu, K., Scott, H. M., Tanaka, K. E., Tsang, E., Tsai, M. C., Flynn, J. L., & Chan, J. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1847-1855.2001 · Cited by 536
Wolfe, F., & Michaud, K. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22864 · Cited by 534
The Risk of Mortality in Patients With Psoriasis: Results From a Population-Based Study
Gelfand, J. M., Troxel, A. B., Lewis, J. D., Kurd, S. K., Shin, D. B., Wang, X., Margolis, D. J., & Strom, B. L. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.12.1493 · Cited by 533
Menter, A., Feldman, S. R., Weinstein, G. D., Papp, K., Evans, R., Guzzo, C., Li, S., Dooley, L. T., Arnold, C., & Gottlieb, A. B. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.07.017 · Cited by 516
Self-citationGordon, K. B., Langley, R. G., Leonardi, C., Toth, D., Menter, M. A., Kang, S., Heffernan, M., Miller, B., Hamlin, R., Lim, L., et al. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.027 · Cited by 510
Self-citationImpact of Obesity and Smoking on Psoriasis Presentation and Management
Herron, M. D., Hinckley, M., Hoffman, M. S., Papenfuss, J., Hansen, C. B., Callis, K. P., & Krueger, G. G. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.12.1527 · Cited by 504
Setty, A. R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.15.1670 · Cited by 485
A Randomized Trial of Etanercept as Monotherapy for Psoriasis
Gottlieb, A. B. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.12.1627 · Cited by 470
Self-citationDrug-induced systemic lupus erythematosus associated with etanercept therapy
Shakoor, N., Michalska, M., Harris, C. A., & Block, J. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07714-0 · Cited by 458
Lee, J., Slifman, N. R., Gershon, S. K., Edwards, E. T., Schwieterman, W. D., Siegel, J. N., Wise, R. P., Brown, S. L., Udall, J. N., & Braun, M. M. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10583 · Cited by 443
Quality of Life in Patients with Psoriasis: A Systematic Literature Review
de Korte, J., Mombers, F. M. C., Bos, J. D., & Sprangers, M. A. G. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2003.09110.x · Cited by 441
Nair, R. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1349 · Cited by 404
Efalizumab for Patients With Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial
Gordon, K. B., Papp, K. A., Hamilton, T. K., Walicke, P. A., Dummer, W., Li, N., Bresnahan, B. W., Menter, A., & for the Efalizumab Study Group (2003) · JAMA · doi:10.1001/jama.290.23.3073 · Cited by 391
Self-citationEtanercept Treatment for Children and Adolescents with Plaque Psoriasis
Paller, A. S., Siegfried, E. C., Langley, R. G., Gottlieb, A. B., Pariser, D., Landells, I., Hebert, A. A., Eichenfield, L. F., Patel, V., Creamer, K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa066886 · Cited by 391
Self-citationBozkurt, B., Torre-Amione, G., Warren, M. S., Whitmore, J., Soran, O. Z., Feldman, A. M., & Mann, D. L. (2001) · Circulation · doi:10.1161/01.cir.103.8.1044 · Cited by 388
PRODANOWICH, S., MA, F., TAYLOR, J., PEZON, C., FASIHI, T., & KIRSNER, R. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.06.017 · Cited by 384
Slifman, N. R., Gershon, S. K., Lee, J., Edwards, E. T., & Braun, M. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10758 · Cited by 383
Wolfe, F., & Michaud, K. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.09.039 · Cited by 372
Anker, S. D., & Coats, A. J. S. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00470-9 · Cited by 367
Determinants of quality of life in patients with psoriasis: A study from the US population
Gelfand, J. M., Feldman, S. R., Stern, R. S., Thomas, J., Rolstad, T., & Margolis, D. J. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.04.014 · Cited by 367
Self-citationLebwohl, M., Christophers, E., Langley, R., Ortonne, J. P., Roberts, J., & Griffiths, C. E. M. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.6.719 · Cited by 363
Self-citationMethotrexate in psoriasis: Revised guidelines
Roenigk, H. H., Auerbach, R., Maibach, H. I., & Weinstein, G. D. (1988) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(88)80237-8 · Cited by 357
The carcinogenic risk of treatments for severe psoriasis
Stern, R. S., Laird, N., & Study, F. T. P. F.-U. (1994) · Cancer · doi:10.1002/1097-0142(19940601)73:11<2759::aid-cncr2820731118>3.0.co;2-c · Cited by 354
Psoriasis is associated with lipid abnormalities at the onset of skin disease
Mallbris, L., Granath, F., Hamsten, A., & Ståhle, M. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.11.1079 · Cited by 353
Krueger, G. G., Papp, K. A., Stough, D. B., Loven, K. H., Gulliver, W. P., & Ellis, C. N. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.127247 · Cited by 338
Onset of multiple sclerosis associated with anti-TNF therapy
Sicotte, N. L., & Voskuhl, R. R. (2001) · Neurology · doi:10.1212/wnl.57.10.1885 · Cited by 322
Kapetanovic, M. C., Saxne, T., Sjöholm, A., Truedsson, L., Jönsson, G., & Geborek, P. (2006) · Rheumatology · doi:10.1093/rheumatology/kei193 · Cited by 319
The carcinogenic risk of treatments for severe psoriasis
Dahl, M. V. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)90084-5 · Cited by 318
Robinson, W. H., Genovese, M. C., & Moreland, L. W. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200109)44:9<1977::aid-art345>3.0.co;2-6 · Cited by 310
Sterry, W., Strober, B. E., Menter, A., & on behalf of the International Psoriasis Council (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08068.x · Cited by 310
Self-citationThe Risk of Lymphoma in Patients with Psoriasis
Gelfand, J. M., Shin, D. B., Neimann, A. L., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700410 · Cited by 304
Restraining mycobacteria: Role of granulomas in mycobacterial infections
Saunders, B. M., & Cooper, A. M. (2000) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2000.00933.x · Cited by 303
A classification of psoriasis vulgaris according to phenotype
Griffiths, C. E. M., Christophers, E., Barker, J. N. W. N., Chalmers, R. J. G., Chimenti, S., Krueger, G. G., Leonardi, C., Menter, A., Ortonne, J.-P., & Fry, L. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07675.x · Cited by 295
Self-citationSmith, C. H., Anstey, A. V., Barker, J. N. W. N., Burden, A. D., Chalmers, R. J. G., Chandler, D., Finlay, A. Y., Grifitths, C. E. M., Jackson, K., McHugh, N. J., et al. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06893.x · Cited by 275
Fomin, I., Caspi, D., Levy, V, Varsano, N., Shalev, Y., Paran, D., Levartovsky, D., Litinsky, I., Kaufman, I., Wigler, I., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.036434 · Cited by 267
Shapiro, J., Cohen, A. D., David, M., Hodak, E., Chodik, G., Viner, A., Kremer, E., & Heymann, A. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.09.017 · Cited by 263
An Italian Study on Psoriasis and Depression
Esposito, M., Saraceno, R., Giunta, A., Maccarone, M., & Chimenti, S. (2006) · Dermatology · doi:10.1159/000090652 · Cited by 249
Gelfand, J. M., Berlin, J., Van Voorhees, A., & Margolis, D. J. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.11.1425 · Cited by 249
Self-citationZein, N. N., & for the Etanercept Study Group (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.025 · Cited by 248
Kaine, J., Kivitz, A., Birbara, C. A., & Luo, A. Y. (2007) · PubMed · Cited by 246
Relationship Between Smoking and the Clinical Severity of Psoriasis
Fortes, C., Mastroeni, S., Leffondré, K., Sampogna, F., Melchi, F., Mazzotti, E., Pasquini, P., & Abeni, D. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.12.1580 · Cited by 246
PUVA and cancer risk: the Swedish follow-up study
LindelÖF, Sigurgeirsson, Tegner, LarkÖ, Johannesson, Berne, Ljunggren, Andersson, Molin, Nylander-Lundqvist, et al. (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02928.x · Cited by 236
Hahn, B. H., Grossman, J., Chen, W., & McMahon, M. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.02.004 · Cited by 234
Stern, R. S., & Lunder, E. J. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.12.1582 · Cited by 230
Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis
Jacobsson, L. T. H., Turesson, C., Nilsson, J.-Å., Petersson, I. F., Lindqvist, E., Saxne, T., & Geborek, P. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062497 · Cited by 229
Psychiatric morbidity in psoriasis: A review
Russo, P. A., Ilchef, R., & Cooper, A. J. (2004) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.2004.00078.x · Cited by 227
The risk of malignancy associated with psoriasis.
Margolis, D. J., Bilker, W. B., Hennessy, S., Vittorio, C. C., Santanna, J., & Strom, B. L. (2001) · PubMed · Cited by 226
Alcohol intake: a risk factor for psoriasis in young and middle aged men?
Poikolainen, K., Reunala, T., Karvonen, J., Lauharanta, J., & Kärkkäinen, P. (1990) · BMJ · doi:10.1136/bmj.300.6727.780 · Cited by 225
Problems encountered during anti-tumour necrosis factor therapy
Desai, S. B., & Furst, D. E. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.06.002 · Cited by 221
Ostuni, P., Botsios, C., Punzi, L., Sfriso, P., & Todesco, S. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.7.686 · Cited by 217
Connections between psoriasis and Crohn's disease
Najarian, D. J., & Gottlieb, A. B. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.540 · Cited by 213
Self-citationMenter, A. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.1.31 · Cited by 211
Self-citationShikiar, R., Willian, M. K., Okun, M. M., Thompson, C. S., & Revicki, D. A. (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-71 · Cited by 210
Autoimmune disease in first-degree relatives of patients with multiple sclerosis
Broadley, S. A., Deans, J., Sawcer, S. J., Clayton, D., & Compston, D. A. S. (2000) · Brain · doi:10.1093/brain/123.6.1102 · Cited by 210
Peterson, J. R., Hsu, F. C., Simkin, P. A., & Wener, M. H. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.11.1078 · Cited by 208
Barcellos, L. F., Kamdar, B. B., Ramsay, P. P., DeLoa, C., Lincoln, R. R., Caillier, S., Schmidt, S., Haines, J. L., Pericak-Vance, M. A., Oksenberg, J. R., et al. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70552-x · Cited by 206
The Benefit/Risk Profile of TNF-Blocking Agents: Findings of a Consensus Panel
Hochberg, M. C., Lebwohl, M. G., Plevy, S. E., Hobbs, K. F., & Yocum, D. E. (2005) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2004.11.006 · Cited by 203
Self-citationLeukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents.
Mohan, N., Edwards, E. T., Cupps, T. R., Slifman, N. R., Jong-Hoon, L., Siegel, J. N., & Braun, M. M. (2004) · PubMed · Cited by 200
Excess Mortality Related to Alcohol and Smoking Among Hospital-Treated Patients With Psoriasis
Poikolainen, K., Karvonen, J., & Pukkala, E. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.12.1490 · Cited by 200
Reactivation of Latent Granulomatous Infections by Infliximab
Wallis, R. S., Broder, M., Wong, J., Lee, A., & Hoq, L. (2005) · Clinical Infectious Diseases · doi:10.1086/429996 · Cited by 191
Kapetanovic, M. C., Saxne, T., Nilsson, J.-A., & Geborek, P. (2006) · Rheumatology · doi:10.1093/rheumatology/kel366 · Cited by 191
Smoking, alcohol and life events related to psoriasis among women
POIKOLAINEN, K., REUNALA, T., & KARVONEN, J. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb03380.x · Cited by 189
Smoking and the Risk of Psoriasis in Women: Nurses’ Health Study II
Setty, A. R., Curhan, G., & Choi, H. K. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.06.020 · Cited by 185
Pettey, A. A., Balkrishnan, R., Rapp, S. R., Fleischer, A. B., & Feldman, S. R. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/s0190-9622(03)01479-8 · Cited by 181
Self-citationNational Psoriasis Foundation Clinical Consensus on Disease Severity
Pariser, D. M., Bagel, J., Gelfand, J. M., Korman, N. J., Ritchlin, C. T., Strober, B. E., Van Voorhees, A. S., Young, M., Rittenberg, S., Lebwohl, M. G., et al. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.2.239 · Cited by 175
Self-citationElkayam, O. (2004) · Seminars in Arthritis and Rheumatism · doi:10.1053/j.semarthrit.2003.10.003 · Cited by 173
Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept.
Mease, P. J., Ritchlin, C. T., Martin, R. W., Gottlieb, A. B., Baumgartner, S. W., Burge, D. J., & Whitmore, J. B. (2004) · PubMed · Cited by 157
Self-citationInfliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis
Gottlieb, A. B., Chaudhari, U., Mulcahy, L., Li, S., Dooley, L. T., & Baker, D. G. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.307 · Cited by 156
Self-citationGottlieb, A. B., Masuda, S., Ramamurthi, R., Abdulghani, A. A., Romano, P., Chaudhari, U., Dooley, L. T., Fasanmade, A. A., & Wagner, C. L. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.10 · Cited by 153
Self-citationThe Salford Psoriasis Index: an holistic measure of psoriasis severity
Kirby, B., Fortune, D. G., Bhushan, M., Chalmers, R. J. G., & Griffiths, C. E. M. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03418.x · Cited by 152
Relapse, rebound, and psoriasis adverse events: An advisory group report
Carey, W. D., Glazer, S. D., Gottlieb, A. B., Lebwohl, M., Leonardi, C. L., Menter, A., Papp, K. A., Rundle, A. C., & Toth, D. P. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.10.029 · Cited by 149
Self-citationWerther, W., González, T., O'Connor, S. L., McCabe, S., Chan, B., Hotaling, T. E., Champe, M., Fox, J. A., Jardieu, P. M., Berman, P. W., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.4986 · Cited by 148
Dubertret, L., Sterry, W., Bos, J. D., Chimenti, S., Shumack, S. P., Larsen, C. G., Shear, N. H., Papp, K. A., & CLEAR Multinational Study Group (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07344.x · Cited by 143
The Burden of Psoriasis Is Not Determined by Disease Severity Only
Heydendael, V. M. R., de Borgie, C. A. J. M., Spuls, P. I., Bossuyt, P. M., Bos, J. D., & de Rie, M. A. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1111/j.1087-0024.2004.09115.x · Cited by 139
Smith, K. J., & Skelton, H. G. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.117725 · Cited by 137
Krueger, G. G., Langley, R. G. B., Finlay, A. Y., Griffiths, C. E. M., Woolley, J. M., Lalla, D., & Jahreis, A. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06948.x · Cited by 136
Feldman, S. R., Gordon, K. B., BALA, M. M., Evans, R., Li, S., Dooley, L. T., Guzzo, C. A., Patel, K. R., Menter, A., & Gottlieb, A. B. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06510.x · Cited by 133
Self-citationReich, K., Nestle, F. O., Papp, K. A., Ortonne, J. ‐., Wu, Y., BALA, M. M., Evans, R., Guzzo, C. A., Li, S., Dooley, L. T., et al. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07237.x · Cited by 131
Lebwohl, M., Bagel, J., Gelfand, J. M., Gladman, D. D., Gordon, K. B., Hsu, S., Kalb, R. E., Kimball, A. B., Korman, N. J., Krueger, G. G., et al. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.08.030 · Cited by 130
Self-citationEfficacy of etanercept in an integrated multistudy database of patients with psoriasis
Gordon, K. B., Korman, N. J., Frankel, E., Wang, H., Jahreis, A., Zitnik, R. J., & Chang, T. H. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.11.1088 · Cited by 119
Self-citationInfection complications associated with the use of biologic agents
Bresnihan, B., & Cunnane, G. (2003) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(02)00101-1 · Cited by 119
Measuring quality of life of patients with different clinical types of psoriasis using the SF-36
Sampogna, F., Tabolli, S., Söderfeldt, B., Axtelius, B., Aparo, U. L., & ABENI, D. D. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.07071.x · Cited by 115
Alcohol, smoking and psoriasis
Higgins (2000) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2000.00588.x · Cited by 115
Dietary factors and the risk of psoriasis. Results of an Italian case-control study
Naldi, L., Parazzini, F., Peli, L., Chatenoud, L., & CAINELLI, T. (1996) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1996.d01-734.x · Cited by 109
CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab
Mahé, E., Descamps, V., Grossin, M., Fraitag, S., & Crickx, B. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05384.x · Cited by 107
Feldman, S. R., Menter, A., & Koo, J. Y. M. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.05697.x · Cited by 103
Self-citationAggressive cutaneous T-cell lymphomas after TNFα blockade
Adams, A. E., Zwicker, J. I., Curiel, C. N., Kadin, M. E., Falchuk, K. R., Drews, R. E., & Kupper, T. S. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.03.047 · Cited by 96
Efalizumab: a review of events reported during clinical trials and side effects
Scheinfeld, N. S. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.2.197 · Cited by 91
Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies
Fulchiero, G. J., Salvaggio, H. L., Drabick, J. J., Staveley-O’Carroll, K. F., Billingsley, E. M., Marks, J. G., & Helm, K. F. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.12.024 · Cited by 87
Gottlieb, A. B., Casale, T. B., Frankel, E., Goffe, B. S., Lowe, N. J., Ochs, H. D., Roberts, J. L., Washenik, K., Vaishnaw, A. K., & Gordon, K. B. (2003) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(03)01836-x · Cited by 86
Self-citationFeldman, S. R., Kimball, A. B., Krueger, G. G., Woolley, J. M., Lalla, D., & Jahreis, A. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.06.053 · Cited by 83
Self-citationFortune, D. G., Richards, H. L., Kirby, B., McElhone, K., Main, C. J., & Griffiths, C. E. M. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06222.x · Cited by 82
Gottlieb, A. B., Gordon, K. B., Lebwohl, M., Caro, I., Walicke, P. A., Li, N., & Leonardi, C. L. (2004) · PubMed · Cited by 79
Self-citationSevere Neutropenia and Thrombocytopenia Associated with Infliximab
Vidal, F., Fontova, R., & Richart, C. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-3-200308050-00021-w4 · Cited by 78
Alefacept therapy produces remission for patients with chronic plaque psoriasis
Krueger, G. G., & Ellis, C. N. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05239.x · Cited by 76
Ebell, M. H., Siwek, J., Weiss, B. D., Woolf, S. H., Susman, J. L., Ewigman, B., & Bowman, M. A. (2004) · PubMed · Cited by 68
Aplastic anemia following administration of a tumor necrosis factor‐α inhibitor
Kuruvilla, J. G., Leitch, H. A., Vickars, L. M., Galbraith, P. F., Li, C. H., Alsaab, S. O., & Naiman, S. C. (2003) · European Journal Of Haematology · doi:10.1034/j.1600-0609.2003.00115.x · Cited by 67
Dyment, D. A., Sadovnick, A. D., Willer, C. J., Armstrong, H., Cader, Z. M., Wiltshire, S., Kalman, B., Risch, N., & Ebers, G. C. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh123 · Cited by 63
Haider, A. S., Lowes, M. A., Gardner, H., Bandaru, R., Darabi, K., Chamian, F. N., Kikuchi, T., Gilleaudeau, P., Whalen, M. S., Cardinale, I. R., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7442 · Cited by 55
Cardiovascular effects of antidepressant drugs
Glassman, A. H. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199809005-00006 · Cited by 43
VACCINATION OF THE IMMUNOSUPPRESSED ADULT PATIENT WITH RHEUMATOLOGIC DISEASE
Avery, R. K. (1999) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70087-9 · Cited by 37
Atypical CD8+ Cutaneous T-Cell Lymphoma After Immunomodulatory Therapy
Berthelot, C., Cather, J. C., Jones, D. M., & Duvic, M. A. (2006) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2006.n.008 · Cited by 36
Papp, K. A., Camisa, C., Stone, S. P., Caro, I., Wang, X., Compton, P. G., Walicke, P. A., & Gottlieb, A. B. (2005) · Journal of Cutaneous Medicine and Surgery · doi:10.1007/s10227-005-0117-0 · Cited by 25
Self-citationEfalizumab-induced autoimmune pancytopenia
Tom, W. L., Miller, M. D., Hurley, M. Y., Suneja, T., Kudva, G. C., Leonardi, C., & Obadiah, J. M. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07437.x · Cited by 20
Self-citationLong-term Treatment for Severe Psoriasis
Gelfand, J. M. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.9.1191 · Cited by 11
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Cited by
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
Menter, A., Strober, B. E., Kaplan, D. H., Kivelevitch, D., Prater, E. F., Stoff, B., Armstrong, A. W., Connor, C., Cordoro, K. M., Davis, D. M. R., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.11.057 · Cited by 969
Self-citationGreb, J. E., Goldminz, A. M., Elder, J. T., Lebwohl, M. G., Gladman, D. D., Wu, J. J., Mehta, N. N., Finlay, A. Y., & Gottlieb, A. B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.82 · Cited by 922
Self-citationGuidelines of care for the management of psoriasis and psoriatic arthritis
Gottlieb, A., Korman, N. J., Gordon, K. B., Feldman, S. R., Lebwohl, M., Koo, J. Y. M., Van Voorhees, A. S., Elmets, C. A., Leonardi, C. L., Beutner, K. R., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.040 · Cited by 769
Self-citationHidradenitis suppurativa: A comprehensive review
Alikhan, A., Lynch, P. J., & Eisen, D. B. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.11.911 · Cited by 705
Pathirana, D., Ormerod, A., Saiag, P., Smith, C., Spuls, P., Nast, A., Barker, J., Bos, J., Burmester, G., Chimenti, S., et al. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03389.x · Cited by 703
Self-citation
Metadata
- Authors
- Menter, A., Gottlieb, A., Feldman, S. R., Van Voorhees, A. S., Leonardi, C. L., Gordon, K. B., Lebwohl, M., Koo, J. Y. M., Elmets, C. A., Korman, N. J., Beutner, K. R., & Bhushan, R.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 58
- Issue
- 5
- Pages
- 826-850
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W2742484040
- Cited by
- 1,222
- References
- 136
- FWCI
- 24.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.